BIOCHEM INTERNATIONAL, INC. – Trademark Portfolio
Entity Type: 03
BIOCHEM INTERNATIONAL, INC. holds 21 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 19 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include ADVISOR, OXILINK, AUTOCORR, SURGIVET, and CAPNOCHECK. The owner is based in WAUWATOSA, WI.
11311 WEST LOCUST ST.
WAUWATOSA, WI 53222
Showing of trademarks Trademarks
Trademark Classifications
BIOCHEM INTERNATIONAL, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does BIOCHEM INTERNATIONAL, INC. have?
BIOCHEM INTERNATIONAL, INC. has 21 U.S. trademarks filed with the USPTO. Of these, 6 registered, 4 abandoned, 11 cancelled.
What trademark classes does BIOCHEM INTERNATIONAL, INC. file in?
BIOCHEM INTERNATIONAL, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 1 (Chemicals), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are BIOCHEM INTERNATIONAL, INC.'s most well-known trademarks?
BIOCHEM INTERNATIONAL, INC.'s registered trademark portfolio includes well-known marks such as ADVISOR, OXILINK, AUTOCORR, SURGIVET, and CAPNOCHECK. These are among 6 currently registered trademarks in the portfolio.
What is BIOCHEM INTERNATIONAL, INC.'s trademark registration success rate?
BIOCHEM INTERNATIONAL, INC. has a 29% trademark registration rate, with 6 out of 21 resolved applications resulting in successful registration. Currently, 0 applications are pending review.